ZUP1 and acute myeloid leukemia: Considering the potential significance of wt SYK as well as constitutively activated SYK in AML pathology and proposed role in drug resistance, we were interested in further exploring the loss of SYK protein in response to treatment with DUB inhibitors as a potential novel approach to treatment of AML.